Print

ISS P-001

Phase I safety and immunogenicity trial of recombinant HIV-1 Tat protein in HIV-1 uninfected volunteers

Trial Details:

I Completed
Instituto Superiore di Sanit September 01, 2003
Tat vaccine Tat
Tat vaccine Protein
Italy 32
http://www.iss.it/